Liam Ratcliffe - 10 Nov 2021 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Director
Signature
/s/ Matthew Batters, as attorney-in-fact for Liam Ratcliffe
Issuer symbol
ARVN
Transactions as of
10 Nov 2021
Net transactions value
-$11,527,510
Form type
4
Filing time
15 Nov 2021, 20:45:43 UTC
Previous filing
09 Nov 2021
Next filing
16 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Sale $167,013 -1,852 -0.27% $90.18 673,849 10 Nov 2021 See footnote F1, F2
transaction ARVN Common Stock Sale $133,560 -1,498 -0.22% $89.16 672,351 10 Nov 2021 See footnote F2, F3
transaction ARVN Common Stock Sale $515,760 -5,853 -0.87% $88.12 666,498 10 Nov 2021 See footnote F2, F4
transaction ARVN Common Stock Sale $344,624 -3,956 -0.59% $87.11 662,542 10 Nov 2021 See footnote F2, F5
transaction ARVN Common Stock Sale $17,231 -199 -0.03% $86.59 662,343 10 Nov 2021 See footnote F2, F6
transaction ARVN Common Stock Sale $489,591 -5,582 -0.84% $87.71 656,761 11 Nov 2021 See footnote F2, F7
transaction ARVN Common Stock Sale $1,555,468 -18,007 -2.7% $86.38 638,754 11 Nov 2021 See footnote F2, F8
transaction ARVN Common Stock Sale $3,111,333 -36,210 -5.7% $85.92 602,544 11 Nov 2021 See footnote F2, F9
transaction ARVN Common Stock Sale $1,499,886 -17,449 -2.9% $85.96 585,095 12 Nov 2021 See footnote F2, F10
transaction ARVN Common Stock Sale $814,474 -9,660 -1.7% $84.31 575,435 12 Nov 2021 See footnote F2, F11
transaction ARVN Common Stock Sale $1,072,100 -12,760 -2.2% $84.02 562,675 12 Nov 2021 See footnote F2, F12
transaction ARVN Common Stock Sale $1,510,122 -17,752 -3.2% $85.07 544,923 15 Nov 2021 See footnote F2, F13
transaction ARVN Common Stock Sale $296,347 -3,532 -0.65% $83.90 541,391 15 Nov 2021 See footnote F2, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.75 to $90.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
F2 The reported shares are held directly by AI Biotechnology LLC ("AIB"), a limited liability company of which the reporting person is the holder of units that are treated as profits interest units. The units owned by the reporting person do not convey a right to vote or dispose of the shares of the Issuer's Common Stock held by AIB. The reporting person disclaims beneficial ownership of all shares held by AIB and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose except to the extent of his pecuniary interest therein.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.68 to $89.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.66 to $88.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.65 to $87.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5).
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.57 to $86.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (6).
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.07 to $88.065, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (7).
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.06 to $87.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (8).
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.25 to $86.055, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (9).
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.15 to $86.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (10).
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.14 to $85.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (11).
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (12).
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.57 to $85.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (13).
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.75 to $84.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (14).